Keivan Zoufan, DDS, MDS
Endodontics · Cupertino
- Medicare standing
- 1 flag on the record
- Listed below.
- Plans that list them
- Not verified
- Not the same as out of network.
- Office
- 1
On the public record
- Medicare does not list them as allowed to order and refer
Offices
1 location
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Zoufan’s office at (310) 592-0731 to ask if they take your plan before you enroll.
California Medical Board record
Licence C52700 · Cancelled
Licence status: Cancelled · since 2007 · University of Karachi, Dow Medical College.
License has been voluntarily canceled, or the license has been expired for at least five years and has not been renewed. No practice is permitted.
Matched on the licence number without its letter prefix; check the name before relying on it.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Drugs they prescribed that Part D paid
$523
Pharmacies billed $523 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
79 generic and 0 brand-name prescriptions · $523 in drug cost · 70 antibiotic prescriptions to 56 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Amoxicillin-Clavulanate Potass | 55 | $384 | $7 |
| Azithromycin | 12 | $80 | $7 |
Year by year
| 2024 | 79 | 57 | None | 0% | $523 |
| 2023 | 70 | 51 | None | None | $642 |
| 2022 | 67 | 54 | None | 0% | $653 |
| 2021 | 48 | 34 | None | None | $363 |
| 2020 | 40 | 32 | None | None | $348 |
| 2019 | 35 | 29 | None | None | $329 |
| 2018 | 40 | 29 | 28% (11) | None | $316 |
| 2017 | 47 | 30 | None | 0% | $435 |
| 2016 | 29 | 27 | None | None | $347 |
| 2015 | 35 | 22 | None | 0% | $308 |
| 2014 | 13 | 11 | None | 0% | $194 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 1 drug
| Amoxicillin-Clavulanate Potass | 50 | $563 | $11 |
2022: 1 drug
| Amoxicillin-Clavulanate Potass | 47 | $513 | $11 |
2021: 1 drug
| Amoxicillin-Clavulanate Potass | 32 | $299 | $9 |
2020: 1 drug
| Amoxicillin-Clavulanate Potass | 25 | $253 | $10 |
2019: 1 drug
| Amoxicillin-Clavulanate Potass | 25 | $252 | $10 |
2018: 1 drug
| Amoxicillin-Clavulanate Potass | 23 | $209 | $9 |
2017: 1 drug
| Amoxicillin-Clavulanate Potass | 27 | $292 | $11 |
2016: 1 drug
| Amoxicillin-Clavulanate Potass | 21 | $249 | $12 |
2015: 1 drug
| Amoxicillin-Clavulanate Potass | 13 | $171 | $13 |
Money from drug and device companies
$190 in 2023
| 2023 | 1 | 1 | None | $190 |
| 2022 | 1 | 1 | $50 | $50 |
| 2021 | 1 | 1 | None | $20 |
| 2020 | 2 | 2 | None | $31 |
| 2019 | 1 | 1 | None | $115 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| J. Morita USA | None | $190 | 1 payment
|
See the published payment
| J. Morita USA | Meals · 2023-03-24 | None | $190 |
See earlier years (2022, 2021, 2020, 2019)
2022: $50
| Septodont | Bioroot Flow (Sample) | $50 | 1 payment
|
2021: $20
| Sonendo | Gentlewave Console | $20 | 1 payment
|
2020: $31
| Carl Zeiss Meditec | None Specified | $17 | 1 payment
|
| Sonendo | Gentle Wave Root Canal Therapy Console and Handpiece | $14 | 1 payment
|
2019: $115
| Sonendo | Gentle Wave Root Canal Therapy Console and Handpiece | $115 | 1 payment
|
Professional record
- NPI
- 1881608784
- Licence
- AZ 6120, CA 52700, CT 009797, NY 000032California C52700: Cancelled
More record details
- Sole proprietor
- Yes
- Medicaid ID
- NY 02701531
- Taxonomy
- Federal specialty code 1223E0200X (1223E0200X); Federal specialty code 1223G0001X (1223G0001X)
- Mailing address
- 10055 Miller Ave, Suite 103, Cupertino, CA, 95014
- NPI first listed
- 2006-07-28
- NPI last updated
- 2013-03-04
This is when the NPI record was last certified, not a medical board exam.